Focus area
Precision Medicine
Genomically guided, individualised diagnostics that match the right test and therapy to the right patient.
Latest
Biomarkers
AI foundation models extract quantitative MRI biomarkers for knee osteoarthritis triage
Significance 7/10 Molecular DxRb Immunohistochemistry Detects CDK4/6 Inhibitor Resistance Missed by NGS in Metastatic Breast Cancer
Significance 7/10 BiomarkersAI Model Predicts Druggable Mutation Probability Before Genomic Profiling in Lung Cancer
Significance 7/10 BiomarkersCompanion Diagnostics Cut Oncology Drug Development Time by Nearly a Year, FDA Analysis Shows
Landmark-class Molecular DxSelf-Attention Network Achieves Over 90% Cancer Classification Accuracy From Panel Sequencing Data
Significance 5/10 AI & DataAI in Neuropathology: From Methylation Classifiers to Intraoperative Raman Histology
Significance 6/10 BiomarkersCompanion Diagnostics in Oncology: Comprehensive Review of Platforms, Challenges, and Future Directions
Significance 5/10 Liquid BiopsyMolecular Screening Tools for Colorectal Cancer: From Tissue Mutations to Multi-Omic Liquid Biopsy
Significance 5/10 BiomarkersExosomes in Prostate Cancer: Dual Role as Tumour Promoters and Diagnostic Biomarkers
Significance 4/10 BiomarkersBiomarker-First Drug Development Strategy Demonstrated for IgA-Driven Autoimmune Diseases
Significance 5/10Landmark studies
Precision Medicine
99 studies
Machine Learning Meets Genomics: Convergence for Precision Oncology at the Point of Care
Nature reviews. Cancer
2026
Landmark-class
WHO 5th Edition: Genomics-Driven Reclassification of Myeloid Neoplasms
Journal of clinical pathology
2025
Landmark-class
NCI-MATCH Trial: Lessons from the Largest Tumour-Agnostic Precision Oncology Study
Nature medicine
2023
Landmark-class
Multi-Site Benchmarking Study Defines Analytical Performance Boundaries of Leading ctDNA Assays
Nature biotechnology
2021
Landmark-class
DNA Methylation Profiling Outperforms WHO Grading for Meningioma Prognosis
The Lancet. Oncology
2017
Landmark-class
ELN 2017 Recommendations Establish Genomic Risk Classification and MRD Framework for AML
Blood
2016
Landmark-class
Nature Medicine Review Positions Liquid Biopsy Across the Full Cancer Care Continuum
Nature medicine
2025
Landmark-class
Lung Cancer in Never-Smokers: NGS-Driven Genomic Profiling Guides Targeted Therapy
JAMA
2025
Landmark-class
Cancer of Unknown Primary: Molecular Profiling Transforms a Diagnostic Dead End
Nature reviews. Clinical oncology
2025
Landmark-class
Multiomics Tumour Profiling Guides Personalized Melanoma Treatment in Prospective TuPro Study
Nature medicine
2025
Landmark-class
Broad 324-Gene Panel Identifies More Matched Therapies but No Outcome Gain in Advanced Cancers
Nature medicine
2025
Landmark-class
Polygenic Risk Scores Poised to Reshape Precision Medicine Across Diseases
Clinical chemistry
2025
Landmark-class
pi-HuB: International Initiative Maps the Complete Human Proteome for Precision Medicine
Nature
2024
Landmark-class
BEACON CRC Biomarker Analysis Reveals Resistance Mechanisms to BRAF-Targeted Therapy via ctDNA Profiling
Nature medicine
2024
Landmark-class
Molecular Tumor Boards: Evolving Role in Precision Oncology and Biomarker Interpretation
Nature reviews. Clinical oncology
2023
Landmark-class
NTRK Fusion Testing in Thyroid Carcinoma: Expert Consensus on a Diagnostic Algorithm
JAMA oncology
2023
Landmark-class
Practical Guide to Using Circulating Tumor DNA in Cancer Treatment Decisions
JAMA oncology
2022
Landmark-class
AI Predicts Genetic Alterations from H&E Slides: Systematic Review of the Evidence
The Journal of pathology
2022
Landmark-class
Deep Learning in Oncology: From Digital Pathology to Multi-Omics Integration
Genome medicine
2021
Landmark-class
National Academies Workshop: Best Practices for Computational Methods in Precision Oncology
JAMA oncology
2020
Landmark-class
Molecular Profiling for Precision Oncology: From NGS Panels to Liquid Biopsies
Genome medicine
2020
Landmark-class
AI-Powered Digital Pathology: New Biomarker Discovery Tools for Precision Oncology
Nature reviews. Clinical oncology
2019
Landmark-class
WINTHER Trial Shows Combined DNA and RNA Profiling Improves Precision Oncology Matching
Nature medicine
2019
Landmark-class
Apolipoprotein Profiling by Mass Spectrometry Enables Precision Cardiovascular Risk Assessment
Annals of clinical biochemistry
2019
Landmark-class
Liquid Biopsies for Early Cancer Detection: Promise and Biological Challenges
NPJ precision oncology
2017
Landmark-class
Show all 99 studies
Molecular Genetics of Gliomas Drives New Classification and Therapy Paradigm
Nature reviews. Clinical oncology
2016
Landmark-class
Clinical NGS in Pediatric Oncology Yields Actionable Findings in Two-Thirds of High-Risk Cases
Genome medicine
2016
Landmark-class
Antimicrobial Resistance Mechanisms in M. tuberculosis: A Translational Framework
Clinical microbiology reviews
2026
Significance 7/10
AI and Machine Learning Transform Predictive Biomarker Discovery in Oncology
Nature reviews. Clinical oncology
2026
Significance 7/10
Precision Oncology 2025 in Review: New Targets, Liquid Biopsy, and AI-Driven Insights
Cancer discovery
2025
Significance 7/10
Drug-Resistant Tuberculosis: Rapid Diagnostics and Shorter Oral Regimens Offer New Hope
Clinical microbiology reviews
2025
Significance 7/10
Lancet Series: Precision Monitoring and AI-Driven Diagnostics Are Reshaping Transplant Medicine
Lancet (London, England)
2025
Significance 7/10
Pharmacogenomic Testing Evolves From Targeted Genotyping Toward Sequencing-Based Approaches
Annals of laboratory medicine
2025
Significance 7/10
Immunotherapy Advances in Squamous Lung Cancer: Biomarker Challenges and Emerging Multi-Omics Strategies
Nature reviews. Clinical oncology
2025
Significance 7/10
Precision Imaging in Oncology: Bridging the Gap Between Liquid Biopsy and Treatment Monitoring
The Lancet. Oncology
2025
Significance 7/10
Patient-Derived Xenograft Models for Functional Precision Oncology in the AI Era
Nature reviews. Cancer
2024
Significance 7/10
Multiplexed Tissue Imaging Poised to Transform Precision Oncology Workflows
Cancer discovery
2024
Significance 7/10
Treatment Landscape for Nodal Peripheral T-Cell Lymphomas Moving Toward Biomarker-Driven Subtype-Specific Therapy
Blood
2024
Significance 7/10
Capivasertib-Fulvestrant Maintains Quality of Life While Improving PFS in HR-Positive Breast Cancer
The Lancet. Oncology
2024
Significance 7/10
Deep Learning in Cancer Genomics and Histopathology: Applications, Biases, and Future Workflows
Genome medicine
2024
Significance 7/10
AI in Diagnostic Pathology: From Whole-Slide Imaging to FDA-Approved Clinical Tools
Diagnostic pathology
2023
Significance 7/10
Machine Learning for Personalized Drug Dosing: Systematic Review Finds High Potential but Poor Validation
Clinical pharmacology and therapeutics
2023
Significance 7/10
Lancet Seminar Reviews Precision Medicine Opportunities in Type 2 Diabetes Including Pharmacogenomics
Lancet (London, England)
2022
Significance 7/10
Clinical Trial Design Evolves for the Precision Oncology Era
Genome medicine
2022
Significance 7/10
Integrating Computational Pathology and Proteomics to Overcome Tumor Heterogeneity
The Journal of pathology
2022
Significance 7/10
Korean Pan-Cancer Sequencing Reveals Genomic Diversity Versus Western Cohorts
Cancer discovery
2022
Significance 7/10
Inflammation Downregulates Drug-Metabolising Enzymes: Implications for Therapeutic Drug Monitoring
Clinical pharmacology and therapeutics
2021
Significance 7/10
Multimodal Data Integration for Precision Oncology: Merging Genomics, Imaging, and Clinical Data
Nature reviews. Cancer
2021
Significance 7/10
PERMED-01 Trial: Extensive Molecular Profiling Finds Actionable Targets in 71% of Advanced Cancers
Genome medicine
2021
Significance 7/10
SMAD4 Alteration Plus Low MAPK9 Expression Predicts Erlotinib Benefit in Resected Pancreatic Cancer
EBioMedicine
2021
Significance 7/10
AI in Cancer Research: From Molecular Characterisation to Treatment Prediction
Cancer discovery
2021
Significance 7/10
Biomarker-Targeted Therapy Landscape in Gastric Cancer Expands Beyond HER2, MSI and PD-L1
Nature reviews. Clinical oncology
2021
Significance 7/10
Next-Generation Sequencing in Clinical Laboratory Medicine: A Comprehensive Review
Annals of laboratory medicine
2020
Significance 7/10
AI in Pathology: Current Clinical Applications and the Road to Precision Medicine
Journal of clinical pathology
2020
Significance 7/10
When to Order NGS in Oncology: A Practical Guide to Precision Medicine in Clinical Practice
EClinicalMedicine
2020
Significance 7/10
Molecular Diagnostics and Targeted Therapy Transform Management of Advanced Systemic Mastocytosis
Blood
2020
Significance 7/10
Circulating Tumour Cells: From Metastatic Biology to Clinical Liquid Biopsy Applications
Genome medicine
2020
Significance 7/10
Policy Challenges in Genomic Medicine: Reimbursement, FDA Oversight, and Gene Patent Threats
Clinical chemistry
2020
Significance 7/10
MALDI Imaging Mass Spectrometry Poised to Complement IHC in Pathology Workflows
Journal of clinical pathology
2019
Significance 7/10
Circulating Tumour Cells in Prostate Cancer: From Enumeration to Precision Oncology
Clinical chemistry
2019
Significance 7/10
EPA and aspirin fail to reduce colorectal adenoma rates in high-risk screening patients
Lancet (London, England)
2018
Significance 7/10
Point-of-Care Testing Trends: From Wearables and Microfluidics to Mass Spectrometry
Clinical chemistry
2018
Significance 7/10
Precision Medicine in Biliary Tract Cancers: Actionable Mutations and Emerging Targeted Therapies
Cancer discovery
2017
Significance 7/10
Blood-Based Protein Signatures Could Enable Early Cancer Detection
Nature reviews. Cancer
2017
Significance 7/10
Genomic Evolution of Ductal Carcinoma In Situ: Clonal Models of Invasion
The Journal of pathology
2016
Significance 7/10
Technological Considerations for Clinical Cancer Genome Profiling: From FFPE to Liquid Biopsy
Genome medicine
2016
Significance 7/10
Metabolic Imaging Biomarkers Offer a Non-Invasive Window into Brain Tumor Biology
Nature reviews. Clinical oncology
2016
Significance 7/10
Beyond EpCAM: Non-Epithelial Methods for Capturing Circulating Tumor Cells
Clinical chemistry
2016
Significance 7/10
Eliminating MRD as a Therapeutic Endpoint Could Move CLL Treatment Toward Cure
Blood
2015
Significance 7/10
Liquid Biopsy Meets Mutational Signatures: A Framework for Longitudinal Cancer Monitoring
NPJ precision oncology
2026
Significance 6/10
Troponin Variation Interpretation: Reference Change Values Versus Analytical Performance Specifications
Clinical chemistry and laboratory medicine
2025
Significance 6/10
VMAT2 Inhibitors in Movement Disorders: Pharmacogenetics Shapes Personalised Dosing
Lancet (London, England)
2025
Significance 6/10
Emerging Molecular Targets in Breast Cancer: From NGS and Liquid Biopsy to Spatial Transcriptomics
Human pathology
2025
Significance 6/10
AI and Molecular Biomarkers Drive Precision Diagnosis in Lupus Nephritis
EBioMedicine
2025
Significance 6/10
Large Language Models in Precision Oncology: From Screening to Treatment Recommendation
EBioMedicine
2025
Significance 6/10
Comprehensive Review Maps ctDNA Treatment Monitoring Across Lung, Colorectal, and Breast Cancer
NPJ precision oncology
2025
Significance 6/10
AI-Powered Cardiovascular Risk Assessment: A Scoping Review of Machine Learning and Deep Learning Approaches
EClinicalMedicine
2024
Significance 6/10
AI in Neuro-Oncology: Advances in Glioma Diagnosis, Molecular Profiling, and Precision Treatment
NPJ precision oncology
2024
Significance 6/10
Circulating Tumour Cells in Breast Cancer: Current Clinical Validity and Emerging Utility
Clinical chemistry
2024
Significance 6/10
Circulating Tumor Cells: From Metastatic Biology to Precision Medicine Applications
Clinical chemistry
2024
Significance 6/10
Co-Occurring Genomic Alterations in Sarcomas: Secondary Hits That Drive Sarcomagenesis
The Journal of pathology
2023
Significance 6/10
Genetics of Human Infertility: Expanding Demand for Reproductive Genomic Testing
Science (New York, N.Y.)
2023
Significance 6/10
Thyroid Cancer Biomarkers: From Thyroglobulin and Calcitonin Harmonization Challenges to Emerging Diagnostics
Clinical chemistry and laboratory medicine
2022
Significance 6/10
Rethinking Histopathology Reporting: Focus on What Changes Patient Management
Journal of clinical pathology
2022
Significance 6/10
Precision Diagnostics for Advanced Cutaneous Squamous Cell Carcinoma: Liquid Biopsy and Molecular Profiling
NPJ precision oncology
2022
Significance 6/10
AI-Powered Biomarker Evaluation for Personalised Treatment in Breast and Prostate Cancer
Journal of clinical pathology
2021
Significance 6/10
Novel Biomarkers Show Promise for Monitoring Anti-TNF Therapy in IBD
EBioMedicine
2021
Significance 6/10
Patient-Derived Organoids as Predictive Biomarker for Cancer Treatment Response
NPJ precision oncology
2021
Significance 6/10
Sex and Gender Differences in Diagnostics: Implications for Laboratory Reference Ranges
Lancet (London, England)
2020
Significance 6/10
NGS and Flow Cytometry Reshape Treatment Paradigms in Acute Myeloid Leukemia
Clinical pharmacology and therapeutics
2020
Significance 6/10
Software-Assisted Decision Support in Digital Histopathology: From Biomarker Scoring to Multiplexed Analysis
The Journal of pathology
2020
Significance 6/10
Circulating Tumour DNA in Molecular Oncology: Clinical Applications and Pre-Analytical Considerations
Clinical chemistry and laboratory medicine
2020
Significance 6/10
Epilepsy Diagnostics: From EEG to Genomic Testing and Pharmacogenomics
Lancet (London, England)
2019
Significance 6/10
Personalised Thrombosis Medicine: Genomics Has Not Yet Replaced Functional Coagulation Testing
Blood
2016
Significance 6/10
Precision oncology trials need standardised biomarker reporting to unlock their data
Clinical chemistry
2015
Significance 6/10
Mass Spectrometry as a Phenotypic Complement to Pharmacogenomics in Precision Medicine
Clinical chemistry
2015
Significance 6/10
Single-Dose Lysergide (MM120) Shows Dose-Dependent Anxiety Reduction in GAD Trial
JAMA
2025
Significance 5/10
Brazil Charts a Path for Companion Diagnostics Amid Complex Health System Challenges
The Lancet. Oncology
2016
Significance 5/10
Anxiety Disorders: The Search for Objective Diagnostic Biomarkers
Lancet (London, England)
2021
Significance 3/10